Biovica reports 55% net sales growth in fiscal year 2025/2026
Theis Kipling became CEO, Biovica reported new ESMO data, expanded pharma services, and terminated EU distribution to focus on US.
See the latest news and media coverage for Biovica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of blood tests for cancer monitoring
biovica.comLast updated
In short: Biovica appointed Theis Kipling as CEO, reported significant sales growth, and presented Phase III data validating DiviTum TKa for breast cancer.
Theis Kipling became CEO, Biovica reported new ESMO data, expanded pharma services, and terminated EU distribution to focus on US.
CEO Theis Kipling and CFO Anders Morén will present the report on June 17th, followed by Q&A.
The data from 555 patients show DiviTum TKa captures early, treatment-specific biological response, differentiating between targeted therapy and chemotherapy within 15 days.
Theis brings significant leadership experience to lead Biovica into its next phase, building on scientific foundation, clinical progress, and commercial opportunities.
The cancer diagnostics company Biovica reports an operating result of -18.0 million kronor (-20.3) for the fourth quarter of the broken fiscal year 2025/2026.
UPPSALA, SE / ACCESS Newswire / May 26, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, today announced an expansion of...
UPPSALA, SE / ACCESS Newswire / May 5, 2026 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) - Biovica International AB ("Biovica") today announces that the company's...
UPPSALA, SE / ACCESS Newswire / April 30, 2026 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) - Biovica today announces that three posters including TKa measurements...
Track Biovica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Biovica and other trending companies.